Presentation TCT 2021 SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk Presenter: Nicolas Van Mieghem November 05, 2021
News Conference News TCT 2021 SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years Todd Neale November 05, 2021
Presentation TCT 2021 Perspectives on TEER Trials in Secondary MR (Control Groups, Enrollment Issues, and More) Presenter: Ori Ben-Yehuda November 05, 2021
Presentation TCT 2021 Perspectives on TEER Trials in Primary MR: From Prohibitive to Intermediate and Low Risk Presenter: Joanna Chikwe November 05, 2021
Presentation TCT 2021 Con: Surgery Is the Optimal Therapy TODAY! Presenter: Michael Acker November 05, 2021
Presentation TCT 2021 Pro: TEER Is the Optimal Therapy TODAY! Presenter: Saibal Kar November 05, 2021
Presentation TCT 2021 Emerging Data From the TVT and STS Mitral Registries Presenter: Paul Sorajja November 05, 2021
Presentation TCT 2021 What’s New in the 2020 Valvular Heart Disease Guidelines for Primary and Secondary MR? Presenter: Robert Bonow November 05, 2021
Presentation TCT 2021 Debate 1: Extraplaque Wire Entry – Device-Based Re-Entry Is the Most Reliable Answer Presenter: Arasi Maran November 05, 2021
Presentation TCT 2021 FFR REACT: A Randomized Trial of FFR-Guided PCI Optimization by IVUS Versus No Optimization Presenter: Joost Daemen November 05, 2021
Presentation TCT 2021 How to Survive Complications of CTO PCI Presenter: Kevin Croce November 05, 2021
Presentation TCT 2021 CHEETAH: Multicenter Study of Continuous Mechanical Aspiration Thrombectomy Prior to PCI in Patients With High Thrombus Burden Presenter: Santhosh Mathews November 05, 2021
Presentation TCT 2021 CAD III: One-year Outcomes of Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Arteries Presenter: Jonathan Hill November 05, 2021